Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Survey of Health Care Professionals Finds Less Than Half (39%) of Respondents Believe Staff Feel Comfortable Addressing a Workplace Violence Crisis


Workplace Violence Prevention Training Index

Crisis Prevention Institute – Workplace Violence Prevention Training Index

“The Workplace Violence Prevention Training Annual Report for Health Care will help everyone understand the challenges health care workers face and provide key insights to help improve their working environments and provide the very best care and outcomes for the patients.”

Today, Crisis Prevention Institute (CPI), the worldwide leader in evidence-based de-escalation and crisis prevention training, published the first-of-its-kind Workplace Violence Prevention Training Annual Report for Health Care. This inaugural report includes the findings from the Workplace Violence Prevention Training Survey CPI conducted from September 2022 to January 2023. The survey secured responses from 3,155 health care professionals, who had a median of 11 years of experience and worked in hospitals with a median size of 99 beds.

CPI conducted this quantitative research to assess the state of workplace violence prevention training in health care, and to support conflict resolution preparedness as violence in health care workplaces continues to rise. The Workplace Violence Prevention Training Annual Report for Health Care includes assessments and results from the survey, with meaningful recommendations to help health care professionals improve safety so they can continue to fulfill their most basic promises for patients.

The Workplace Violence Prevention Training survey remains open to gather real-time data that will help health care professionals understand how they compare to others in their field and how they can enhance safety in their workplaces. Each year, CPI will publish a new Workplace Violence Prevention Training Annual Report for Health Care with the data collected from the previous year.

“Given the health care industry’s compounding challenges of increased workplace violence and staffing shortages, we knew there was an opportunity to provide health care systems with a tool to quickly assess their workplace violence prevention training programs, says Tony Jace, chief executive officer, Crisis Prevention Institute. “The Workplace Violence Prevention Training Annual Report for Health Care will help everyone understand the challenges health care workers face and provide key insights to help improve their working environments and provide the very best care and outcomes for the patients.”

As part of this initiative, health care workers can take the survey to get a score related to workplace violence prevention training at their organization — the Workplace Violence Prevention Training Index. They can use this index as a baseline to see where they stand compared to others in their industry. Those who have concerns about the safety of their workplace can take the survey, get their score, and share the findings with their teams to encourage administrators to prioritize teaching the skills needed to identify, prevent and de-escalate violence and crises in the workplace.

Using the data from the survey, CPI created standardized indices to benchmark progress toward workplace violence prevention training in the health care industry. CPI grouped data into two categories to summarize respondents’ feelings around the safety of their workplace and their workplace’s preparedness to resolve conflicts.

  • The Safe Workplace Index (SWI) defines how safe staff feels, how comfortable they are responding to a crisis and their belief in the efficacy of their organization’s current policies in reducing violence.
  • The Workplace Preparedness Index (WPI) provides an assessment of workplace violence committees, level of staff involvement in violence prevention, and de-escalation training frequency.

By organizing responses into these indices, CPI is able to provide survey respondents a single score — the Workplace Violence Prevention Training Index — to group health care professionals into categories of Leaders, Above Average, Below Average or Laggards.

Notable findings in the Workplace Violence Prevention Training Annual Report for Health Care include:

  • Less than half (39%) of respondents believe their staff feel comfortable or very comfortable addressing a crisis
  • Nearly half of all respondents believe they are below average (40%) as a leading safe workplace or lagging behind (9%)
  • Nearly one in five (17%) respondents believe staff feel very or mostly unsafe
  • Less than half (43%) believe their policies against workplace violence are effective or very effective

“The Workplace Violence Prevention Training Index provides a starting place for leaders in health care to learn how they can easily make improvements for their unique health system or organization,” says AlGene Caraulia, vice president of integration and sustainability, CPI. “When leadership commits to implementing workplace violence prevention training, they make it easier for health care workers to fulfill their oath to help people so they can improve patient care and create better outcomes. By helping people bring peaceful resolution to situations that would otherwise turn to conflict, we can help staff, patients and visitors feel safe.”

CPI provides turnkey, scalable and evidence-based workplace violence prevention training programs that are tailored to provide the right skills to each staff member depending on their level of risk within a hospital, ambulatory care or throughout an entire health care system. As a strategy to reduce workplace violence, CPI trains health care professionals to use a person-centered approach to de-escalate life’s daily crisis moments before they become violent.

Since 1980, CPI has helped train more than 16 million people within service-oriented industries and has served its field longer than anyone else. By successfully diagnosing, designing, and implementing thousands of workplace violence prevention programs across the globe, CPI has helped its clients review, assess, and operationalize their workplace violence prevention programs.

About Crisis Prevention Institute

Crisis Prevention Institute is a world-leading training organization specializing in the safe management of disruptive and assaultive behavior with a focus on prevention. Founded in 1980, it has been their mission to reduce the likelihood and severity of workplace violence incidents. Over 17,000 facilities, 39,000 Certified Instructors, and 16 million trained professionals worldwide trust CPI to help create more confident and productive employees.

Share article on social media or email:

Ideal Option Releases 2022 Patient Outcomes Report to Show Effectiveness of Medication-Assisted Treatment for Fentanyl, Heroin, Methamphetamine and Cocaine


Ideal Option, a national leader in outpatient medication-assisted treatment for addiction to opioids and other substances, has released its 2022 Annual Patient Outcomes Report for patients living in North Dakota.

This report contains an aggregated view of patients’ geographic and demographic characteristics, their stage and duration of care, adherence to medication and their substance use over time based on lab specimens collected during 2022 from more than 500 patients.

The data support the effectiveness of treating addiction with FDA-approved medications combined with regular lab testing to verify medication adherence, create accountability and ensure patient safety.

Among North Dakota patients who remained in treatment from initiation to the maintenance stage of care during 2022, the report shows:

  • 91% less total opioid use
  • 96% less fentanyl use
  • 90% less heroin use
  • 81% less methamphetamine use
  • 86% less cocaine use

The report also reveals synthetic drug use continuing to rise among enrolling patients in 2022, particularly fentanyl. Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing.

“Polysubstance use disorder is now the most common diagnosis at Ideal Option,” said Tim Kilgallon, CEO at Ideal Option. “In 2022, over half of all North Dakota patients tested positive for two or more substances at enrollment, and 20% tested positive for three or more substances.”

The data corroborate state reports of the increasingly prevalent role that fentanyl plays in the substance use epidemic. According to Northeast Central Judicial District Presiding Judge Donald Hager, of all the overdose deaths he has seen in recent years in North Dakota, almost all are fentanyl related.

In addition, according to North Dakota Highway Patrol, opioids and amphetamines were the most common drugs in 2021 overdose deaths. Ideal Option data show that standard treatment for opioid use disorder dramatically reduces the use of methamphetamine in patients who test positive for both.

View the full Ideal Option 2022 Annual Patient Outcomes Report for North Dakota here: [https://www.idealoption.com/patient-outcomes.

Ideal Option has helped more than 65,000 patients through a network of nearly 90 outpatient clinics across 11 states: Alaska, Arkansas, Idaho, Maryland, Minnesota, Montana, Nebraska, New Mexico, North Dakota, Oregon and Washington.

With no waitlists and most forms of insurance accepted, including Medicare and Medicaid, patients can typically get started on treatment for fentanyl, heroin, methamphetamine, alcohol, or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of nearly 90 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

Challenges, Opportunities & Technologies for Real-Time Decision Making by CROs and FSPs, Upcoming Webinar Hosted by Xtalks


The increase in the 5 Vs (volume, velocity, variety, veracity and variability) of data, calls for the adoption of modern technology to rein in the complexity and make the data available for driving real-time or near real-time decision making.

Clinical research has been continually transforming through the adoption of new pathways, tools, technologies and techniques. A report by the Institute of Medicine (US) RoundTable on R&D found that an average clinical trial generates up to three million data points and counting. Such developments are increasing the complexity of data collection, cleanup, aggregation and analysis.

Clinical Research Organizations (CROs) and Functional Service Providers (FSPs) play substantial and unique roles in the conduct of clinical trials. They are posed with the challenge of reviewing clinical and operational data during the study, identifying any problems and addressing them sooner rather than later to keep the study running. The increase in the 5 Vs (volume, velocity, variety, veracity and variability) of data, calls for the adoption of modern technology to rein in the complexity and make the data available for driving real-time or near real-time decision making.

CROs and FSPs need technology platforms that meet certain criteria that are uniquely different from the typical sponsor needs. For example, a highly interoperable platform to connect with diverse clinical ecosystems that their sponsors would have etc. Also, adoption of processes like RBQM/RBM is on the rise creating opportunities for these service providers to expand their offerings like central monitoring, risk-based data management, etc.

These evolving needs require agile technology platforms that can be configured to make data and insights available for real-time decision making.

Many CROs and FSPs have successfully met these challenges, created opportunities for growth in the marketplace and are advancing clinical research.

Register for this webinar to discover the featured speakers’ perspectives and experiences in selecting and adopting a data and analytics infrastructure that brings faster time to insights managing multiple data sources.

Join Venu Mallarapu (Moderator), VP, Global Strategy & Operations, eClinical Solutions; Katrina Rice, Chief Delivery Officer, Biometrics Services, eClinical Solutions; Mahesh Iyer, Vice-President, GDO Innovation Lead and Head, GDO India, Parexel; Lori McDermott RN, BSN, MSc, PMP, Chief Operating Officer, LumaBridge, for the live webinar on Wednesday, May 3, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Accelerating Clinical Research: Challenges, Opportunities & Technologies for Real-Time Decision Making by CROs and FSPs.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

DecisionHealth announces its 20th Annual Home Health Coding Summit, taking place from August 14–16, 2023, in Phoenix, Arizona.


News Image

“Whether you are a novice coder or have been coding for 20 years, you will always come away with greater knowledge and an increased confidence regarding the importance of your work.”—Nanette Minton

Now in its 20th year, the Home Health Coding Summit provides home health coding professionals with over 20 hours of intermediate and advanced code training. DecisionHealth is excited to announce this year’s summit will be held from August 14–16, 2023, at the Hilton Phoenix Resort at the Peak in Arizona. Attendees will get a first look at FY 2024 code, guidelines, and OASIS changes, as well as the tools and resources they need to code accurately and compliantly.

When asked what she is looking forward to most this year, Sherri Parson, RN, HCS-D, HCS-O, HCS-H, COS-C, chief compliance officer/director of operations with Infusion Health, said, “I’m excited for another year of great instruction and training at the Home Health Coding Summit. A highlight for me has been knowledgeable presenters sharing upcoming industry changes and details before they go into effect. I’ve been coming for many years and always walk away with something new that I’ve learned. This is a great networking and information-rich conference!”

Other agenda highlights for 2023 include:


  • Coding, OASIS, and Documentation QA Boot Camp preconference on Monday, August 14;
  • Two main conference tracks with 20+ hours of training, including interactive scenario sessions;
  • A deep dive into the most complicated home health cases, working through actual patient documentation to find the right codes;
  • Disease-specific code training to accurately assign the new mental health codes, as well as COVID-19, circulatory, respiratory, wound, fracture, and joint replacement codes and much more;
  • Documentation collection and QA best practices for those who want to achieve competence and efficiency in OASIS, coding, and documentation;
  • An HCS-D class to help you prepare for the certification exam;
  • Welcome and networking reception to connect with others who share your passion; and
  • Fun coding games and exciting door prizes!


View the agenda at store.decisionhealth.com/home-health-coding-summit.

Nanette Minton, RN, HCS-D, HCS-H, senior clinical coding manager with MAC Legacy, adds, “The Home Health Coding Summit provides a clear advantage to home health and hospice coders. It offers the opportunity for coders to truly dig into the substance of what coding in the home setting is all about. Whether you are a novice coder or have been coding for 20 years, you will always come away with greater knowledge and an increased confidence regarding the importance of your work. The value it provides in terms of content excellence along with quality speakers is invaluable. The opportunity to network with like-minded professionals provides an exceptional edge to the quality of the coder’s work, hands down.”

The Home Health Coding Summit is presented by the Association of Home Care Coding and Compliance (AHCC). The main conference starts on Tuesday, August 15, with the 2023 AHCC Achievement Awards Presentation by Director Jan Milliman. This celebrates and honors home care professionals who have demonstrated a commitment to excellence and have made measurable improvements in their organization.

Attendees will leave with insights from the nation’s top home health coding and OASIS professionals and the tools and resources to sit for a coding credential, earn continuing education credits (CEUs), and advance their career.

For more information, contact a Customer Service representative at 855-225-5341 or e-mail HCEvents@hcpro.com.

Required resources: Participants MUST bring a 2023 ICD-10-CM coding manual (DecisionHealth’s 2023 Complete Home Health ICD-10-CM Diagnosis Coding Manual is available here) OR have a subscription to the Home Health Coding Center.

###

About AHCC

The mission of the Association of Home Care Coding & Compliance (AHCC) is to serve the staff-development needs of the home care industry through education, training, work tools, resources, community-building/networking, and advocacy. AHCC also offers professional certifications for coders and clinicians through the Board of Medical Specialty Coding & Compliance (BMSC). Learn more and become a member at https://ahcc.decisionhealth.com/.

About DecisionHealth

DecisionHealth, an HCPro brand, is the industry’s leading source for home health agencies and medical practice facilities to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, benchmarks, payments, and HIPAA compliance through its flagship publications, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com.

About HCPro

For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.

Share article on social media or email:

The Undefeated Tribe, a Crunch Fitness Franchise, Announces a New $11 MM Flagship Gym in San Marcos, TX


The Undefeated Tribe, a Crunch Franchise, announced plans today for a new $11 MM flagship location that will be the most expensive build in the industry. Spanning over 35,000 square feet and two stories on four acres, this 24/7 gym will feature world-class equipment and full Amenities. Set to open in the winter of 2023 with construction set to begin in April 2023, this club will bring over 100 new jobs to San Marcos, TX, and will make a big impact on the local community.

The Crunch Fitness experience fuses fitness with entertainment to make serious exercise fun. Members will enjoy miles of cardio, tons of weights, hot yoga, a Kid’s Club with a movie theater, the Ride Cycle Studio, HIITZone Training®, Personal Training, tanning, and HydroMassage®. Crunch is also known for innovative group fitness programming and will offer a wide range of motivating classes including BodyWeb with TRX®, Zumba®, Cardio Tai Box, Yoga Body Sculpt, Fat Burning Pilates, and more.

“All will be welcome at our new flagship location, and there truly will be something for everyone,” said Crunch Franchisee Tony Hartl, CEO of The Undefeated Tribe. “Our goal is to get people from all walks of life to come in, get their heart rates up, break a sweat, and leave feeling better about themselves.”

The locally-owned and operated Crunch Fitness will be open and staffed 24/7 and will offer memberships starting at $9.99 per month with no contracts. This club will also offer an exclusive limited-time promotion for their founding members. The first 500 members will join for only $1 and get their 1st month free plus get a free 1-hour personal training session and a free gym bag.

You can enter to win a free one-year All-Access membership and lock in your Founding 500 rate at https://info.crunch.com/rate-reservations.

Working at the also promises to be an experience like no other. Crunch Fitness will also hire over 100 individuals to work at the flagship location, who will be dedicated to helping their community within the fitness, wellness, relaxation, and recovery space. Crunch is on the search for managers, group fitness instructors, personal trainers, customer service representatives, facility technicians, and babysitters to join a team that believes in being the best place to work and workout.

If you are interested in Working Hard, Having Fun and Making History, please apply today at epiccrunchjobs.com.

About The Undefeated Tribe

Founded in 2018 by Tony Hartl, The Undefeated Tribe is one of the fastest growing franchises within the Crunch Fitness system. The Company currently operates locations in Texas and Oklahoma, with many more in development. In 2021 The Undefeated Tribe was selected as the Franchise of the Year for the Crunch Fitness system. The Undefeated Tribe was recognized as the top-performing franchise for its unique accomplishments and excellence in business performance, community service, and brand involvement.

Share article on social media or email:

The Evolution and Impact of ePROs in Clinical Trials, Upcoming Webinar Hosted by Xtalks


To avoid increasing health disparities in clinical trials, underserved groups should be included through PRO-specific ethical guidelines for clinical research so that patient-reported outcomes are collected.

This webinar will examine the importance of electronic patient-reported outcomes (ePROs) and how working at pace with methodological rigour led to the development of the Symptom Burden Questionnaire™ (SBQ™), a new ePRO measure which includes 16 symptoms scales, each measuring a different symptom. The featured speakers will also talk about the feasibility trial of non-pharmacological interventions as part of the Therapies for Long COVID (TLC) study.

To avoid increasing health disparities in clinical trials, underserved groups should be included through PRO-specific ethical guidelines for clinical research so that patient-reported outcomes are collected.

Register for this webinar to learn about the impact of ePROs through a unique ePRO measure that is tailored to individual patient needs.

Join Prof. Melanie Calvert, Professor of Outcomes Methodology, University of Birmingham; Dr. Sarah Hughes, Research Fellow, Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research; Dr. Christel McMullan, Qualitative Research Fellow, Centre for Patient Reported Outcomes Research (CPROR), Institute of Applied Health Research; and Chris Frost, Chief Operations Officer, Aparito, for the live webinar on Thursday, May 4, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit The Evolution and Impact of ePROs in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Enriching High Titer IgG-producing Clones Using Cold-Capture and The Namocell Pala Single Cell Dispenser, Upcoming Webinar Hosted by Xtalks


The process of finding high titer clones typically involves screening of large numbers of clones, making it laborious and time-consuming.

Cloning of Chinese hamster ovary (CHO) cells expressing recombinant antibodies is a crucial step in the development of monoclonal antibody (mAb) therapeutics. It is important to identify clones that produce high yield. However, the heterogeneity of CHO cells can give rise to varied IgG expression among individual cells. Thus, the process of finding high titer clones typically involves screening of large numbers of clones, making it laborious and time-consuming.

Cold-capture is a technique that allows labelling of antibody producing cells with a fluorescent reagent that binds to the antibody molecules when they are transiently present on the cell membrane before release from secretory vesicles. This labelling could enable cell sorting based on the level of fluorescence signal to select higher productivity cells. In this study, the featured speaker sought to test the ability to enrich high titer IgG CHO cell clones by cold-capture, followed by isolation of single cells with the brightest fluorescent signal using the Namocell Pala Single Cell Dispenser — a fully automated dispenser that enables a fast, easy fluorescence and light scatter-based single cell isolation. The speaker will show that their method allowed the identification of clones with an average 3x higher IgG production from the cold-capture labelled cells compared to non-cold-captured cells.

These results suggest that the combination of cold-capture and single cell isolation could be an efficient and economical solution for improving cell line development in recombinant antibody production.

Join this webinar to learn more about the potential of cold-capture-facilitated single cell isolation and cloning to improve the efficiency in identifying high yield clones.

Join Francisco Ramirez, Manager, Application Science, Bio-Techne, for the live webinar on Tuesday, May 2, 2023, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Enriching High Titer IgG-producing Clones Using Cold-Capture and The Namocell Pala Single Cell Dispenser.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Rimidi Announces Integration with MEDITECH Greenfield, Enabling Better Patient Care


News Image

MEDITECH’s support of SMART-on-FHIR is in line with industry best practices for interoperability, and by integrating with Greenfield, we’re able to offer MEDITECH customers a streamlined experience with patient-generated data and the Rimidi platform.

Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, today announced the company is now integrated with MEDITECH Greenfield. As a result of the new collaboration, MEDITECH customers are now able to utilize Rimidi’s cloud-based software platform within their existing workflow, further enhancing efforts to support efficient models of care for chronic disease management through Fast Healthcare Interoperability Resources (FHIR) application programming interface (APIs).

The healthcare industry initially adopted FHIR as the protocol of choice for API-based data exchange to enable a seamless transfer of patient health information from multiple data sources. As the industry continues to strive toward a value-based care model, the overall healthcare API market is expected to increase to $309.86 million by 2032, allowing for more enhanced collaboration to enable better patient care.

Rimidi’s integration with MEDITECH allows clinicians to use Rimidi within their existing MEDITECH workflow. Specifically, the integration:

  • Enables MEDITECH users to see remote patient-generated data from connected devices and Patient Reported Outcomes Measures within disease-specific views in the patient chart for efficient chronic disease management.
  • Provides insights and clinical decision support to drive next best steps in care and close gaps versus practice guidelines to optimize outcomes in patients with complex chronic conditions.

“We’re excited to add MEDITECH to our portfolio of Electronic Health Record integration partners,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “MEDITECH’s support of SMART-on-FHIR is in line with industry best practices for interoperability, and by integrating with Greenfield, we’re able to offer MEDITECH customers a streamlined experience with patient-generated data and the Rimidi platform.”

Dr. Ide will be presenting at the HL7 booth at HIMSS, highlighting Rimidi’s experience implementing their SMART-on-FHIR platform across multiple EHRs, as well as clinical outcomes seen with clients so far. The presentations, FHIR Solutions Showcasing Real-World Implementations, will be held Tuesday, April 18 from 1- 2 p.m. CT and Thursday, April 20 from 1-2 p.m. CT.

For more information on Rimidi and its cloud-based software solutions, visit rimidi.com. To book a meeting with Dr. Ide at HIMSS, please reach out to her directly via LinkedIn, and stop by the HL7 FHIR Booth #138 during the conference.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Twitter and LinkedIn.

Share article on social media or email:



Ideal Option Opens Addiction Medicine Clinic in Bentonville


Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in Bentonville. The new clinic, located at 907 SE Village Loop, Suite 3, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decrease, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to data from the county coroners, the number of fatal drug overdoses in Benton and Washington counties nearly doubled in the past three years — from 42 in 2020 to 74 in 2022.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. In 2022, over half of all Arkansas patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope however, by showing how effective medication-assisted treatment is for reducing substance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 94% less fentanyl use
  • 87% less total opioid use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic in Bentonville is Ideal Option’s ninth location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 89 clinics in 11 states.

“In 2022, Ideal Option helped more than 1,000 patients living in Arkansas get started in recovery,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited to expand our life-saving treatment services to Bentonville and look forward to building relationships within this wonderful community.”

The new Ideal Option clinic in Bentonville is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 907 SE Village Loop, Suite 3, Bentonville, AR 72712.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 89 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email:

PredxBio is bending the survival curve for immunotherapy cancer patients with spatially intelligent biology at AACR 2023


PredxBio is Showcasing at AACR 2023

PredxBio is Showcasing at AACR 2023

We are excited to share our latest innovations in unbiased spatial analytics and explainable AI and demonstrate how our platform can be used to extract valuable information from patient disease pathology samples imaged with any technology.

PredxBio, formerly known as SpIntellx, is set to showcase its innovative platform at the 2023 Annual Meeting of the American Association for Cancer Research in Orlando, Florida from April 15-19. The company will present its explainable AI-powered unbiased spatial analytics platform that integrates multimodal data to reveal the hidden circuitries of the tumor microenvironment and expose the complex network biology of cancer. The PredxBio platform has been designed to address the challenges of managing cancer patients with immunotherapy, as it only works about 20% of the time, and commercialized diagnostic tests do not provide the tools to make better decisions. By analyzing complex signals from multiple spatial omics technologies, including spatial proteomics, spatial transcriptomics, and brightfield pathology images, PredxBio aims to improve prediction accuracies and drive personalized therapeutic options not only for PD1/PDL1 inhibitor-based therapies but also for novel bispecific/multi-specific antibody therapeutics, and cutting edge chimeric antigen receptor (CAR)-T cell therapies.

At the AACR Annual Meeting, PredxBio will showcase its latest innovations in unbiased spatial analytics and explainable AI, demonstrating how its platform can extract valuable information from patient disease pathology samples imaged with any technology including brightfield pathology, spatial proteomics and/or spatial transcriptomics. PredxBio will be presenting a scientific poster (#5445) showcasing its work on cell segmentation-free analysis of multiplexed images with unbiased spatial analytics and explainable AI for predicting disease outcomes.

The first step in the current approaches for extracting high-value knowledge from multiplexed datasets is to segment cells accurately. Despite decades of research, this step remains elusive due to imaging artifacts leading to low-quality cell segmentation. Those artifacts may lead to incorrect cell phenotypes, incomplete cell phenotype atlases, and missing rare cell, fusion cell and/or transition cell types. To address these issues, PredxBio will showcase a segmentation-free approach on a challenging, low-resolution hyperplexed imaging mass cytometry dataset of triple negative breast cancer. This approach discovers functional collections of neighboring pixels highly predictive of disease progression and leads to tumor promoting and tumor restraining microdomains and microdomain-specific network biology predictive of disease outcomes.

“We are unraveling the dynamics of the tumor microenvironment by capturing inter- and intra-cellular communications and their distinct spatial configurations, named microdomains. We believe, deriving spatial network biology within each microdomain is key to understanding tumor initiation, progression, and response to therapy thus enabling better patient outcomes” said B. Dusty Majumdar, PhD, CEO of PredxBio.

The PredxBio platform is designed to improve prediction accuracies and drive personalized therapeutic options for selecting optimal therapeutics based on insights into spatial tumor biology of individual patients and their potential outcomes. With the launch of the PredxBio brand, the company is positioned in spatial biology space with the truly unique capability of unravelling the hidden biological circuitries of cancer to predict patient outcomes with 90%+ accuracy.

“The AACR Annual Meeting is an excellent opportunity for PredxBio to showcase our technology and its potential to revolutionize the field of cancer research,” added S. Chakra Chennubhotla, PhD, Chief of AI and COO of PredxBio. “We are excited to share our latest innovations in unbiased spatial analytics and explainable AI and demonstrate how our platform can be used to extract valuable information from patient disease pathology samples imaged with any technology.”

PredxBio will be presenting at the AACR Annual Meeting from April 15-19, 2023, at booth #974. Attendees are encouraged to stop by to see demonstrations of their software platform and to learn more about how PredxBio is working to advance the field of cancer research.

About PredxBio

PredxBio is a Pittsburgh, PA-based scaling-stage company focused on the development of explainable AI-powered spatial analytics software platforms to decipher the complex cancer biology and accelerate innovation in precision pathology and spatial biology. PredxBio’s solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. PredxBio has already completed engagements with early paying customers including pharma partners who are harnessing PredxBio’s solutions to assess treatment response in immunotherapy.

http://www.predxbio.com

Share article on social media or email: